Search

everythinglearnresearchcommunity

for

Search:↓

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Cholecystokinin may help reduce skin inflammation in psoriasis.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Ichthyosis with confetti is a genetic skin disorder with consistent ectodermal malformations and various KRT10 gene mutations.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Ruxolitinib can cause a delayed skin reaction on the nose.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.